PROTIA Inc. participated in Medlab Middle East 2025, an international medical device exhibition held at the Dubai World Trade Centre in the United Arab Emirates from February 3 to February 6, 2025. This year’s event featured over 800 exhibitors from around the world, attracting more than 20,000 industry professionals.

At Medlab 2025, PROTIA introduced its innovative diagnostic solutions, including the PROTIA Allergy-Q 192D, the world's most comprehensive multiplex allergy diagnostic kit, and the PROTIA Allergy-Q 64D, the first diagnostic kit capable of simultaneously measuring component allergens and drug/chemical allergens. The company also showcased the PROTIA AST DL001, the world's first antibiotic susceptibility test using electrical capacitance, along with ANITIA Canine/Feline/Equine IgE, a multiplex allergy diagnostic kit for pets, and PROTIA ANA Profile 18, an advanced autoimmune diagnostic kit.

By presenting a diverse range of allergy diagnostics, animal allergy diagnostics, and antibiotics susceptibility testing, PROTIA received overwhelmingly positive feedback from attendees. The exhibition recorded a visitor increase of more than 50% compared to Medlab 2024, highlighting the growing global preference for K-medical devices and reaffirming PROTIA’s reputation for cutting-edge technology and innovation in the field of medical diagnostics.

Exhibited Products

1. Human Allergy Diagnostic Test

• PROTIA Allergy-Q 192D
• PROTIA Allergy-Q 64D
• PROTIA Allergy-Q 64G

2. Animal Allergy Diagnostic Test

• ANITIA Canine IgE, IgG
• ANITIA Feline IgE, IgG
• ANITIA Equine IgE

3. Antibiotic Susceptibility Test

• PROTIA AST DL001

4. Diagnostic Equipment

• Q-Smart (Reading device)
• Q-Processor (Processing device)
• Q-Station (Processing and reading device)
• Q-AST 192 Pro (Antibiotic susceptibility diagnostic device)